Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.81 |
| ▸ | MAPT | P10636 | 2/20 | 0.81 |
| ▸ | LMNA | P02545 | 1/20 | 0.81 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.74 |
| ▸ | POLB | P06746 | 1/20 | 0.64 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.54 |
| ▸ | HNF4A | P41235 | 1/20 | 0.53 |
| ▸ | LIG1 | P18858 | 1/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.52 |
| ▸ | MYC | P01106 | 1/20 | 0.52 |
| ▸ | FTO | Q9C0B1 | 1/20 | 0.51 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.50 |
| ▸ | TTR | P02766 | 1/20 | 0.49 |
| ▸ | NPC1 | O15118 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL69960 | 0.93 | ALDH1A1 (0.85) | ALDH1A1MAPTLMNAL3MBTL1POLB | |
| SCHEMBL69132 | 0.91 | ALDH1A1 (0.88) | ALDH1A1MAPTLMNAL3MBTL1POLB | |
| SCHEMBL16224286 | 0.90 | MAPT (0.68) | ALDH1A1MAPTLMNAL3MBTL1POLB | |
| SCHEMBL581124 | 0.90 | ALDH1A1 (1.00) | ALDH1A1MAPTLMNAL3MBTL1POLB | |
| SCHEMBL69716 | 0.88 | ALDH1A1 (0.69) | ALDH1A1MAPTLMNAL3MBTL1POLB | |
| SCHEMBL461660 | 0.85 | ALDH1A1 (1.00) | ALDH1A1MAPTLMNAL3MBTL1POLB | |
| Anthraquinone SCHEMBL8941397 | 0.85 | ALDH1A1 (1.00) | ALDH1A1MAPTLMNAL3MBTL1POLB | |
| SCHEMBL23723959 | 0.85 | FTO (0.73) | ALDH1A1MAPTLMNAL3MBTL1POLB | |
| Hydrochloric Acid SCHEMBL8675457 | 0.84 | ALDH1A1 (0.96) | ALDH1A1MAPTLMNAL3MBTL1POLB | |
| SCHEMBL70265 | 0.83 | ALDH1A1 (0.63) | ALDH1A1MAPTLMNAL3MBTL1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1349822-B1 | FLUORINATED AROMATIC COMPOUNDS AND THE USE OF THE SAME IN LIQUID CRYSTAL MIXTURES | MERCK PATENT GMBH (DE) | 2016-09-28 | — | — | EP | disclosed |
| EP-1349822-B1 | FLUORINATED AROMATIC COMPOUNDS AND THE USE OF THE SAME IN LIQUID CRYSTAL MIXTURES | MERCK PATENT GMBH (DE) | 2016-09-28 | — | — | EP | disclosed |
| US-20160124330-A1 | ELECTROPHOTOGRAPHIC PHOTOSENSITIVE MEMBER, METHOD FOR MANUFACTURING THE SAME, PROCESS CARTRIDGE, AND ELECTROPHOTOGRAPHIC APPARATUS | CANON KABUSHIKI KAISHA (JP) | 2016-05-05 | — | — | US | disclosed |
| WO-2014178258-A1 | ELECTROPHOTOGRAPHIC PHOTOSENSITIVE MEMBER, METHOD FOR MANUFACTURING THE SAME, PROCESS CARTRIDGE, AND ELECTROPHOTOGRAPHIC APPARATUS | CANON KABUSHIKI KAISHA (JP) | 2014-11-06 | — | — | WO | disclosed |
| US-7018685-B2 | Fluorinated aromatic compounds and the use of the same in liquid crystal mixtures | MERCK PATENT GMBH (DE) | 2006-03-28 | — | — | US | disclosed |
| US-20040124399-A1 | Fluorinated aromatic compounds and the use of the same in liquid crystal mixtures | MERCK PATENT GMBH (DE) | 2004-07-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040124399-A1 | Fluorinated aromatic compounds and the use of the same in liquid crystal mixtures | AFF1, AFF2, FLI1 | ALDH1A1 2672/4885MAPT 1288/4885LMNA 1591/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.